NEWLINK GENETICS CORP
A stranger
VSV-EBOVAC: Vaccine safety and immunogenicity signatures of human responses to VSV ZEBOV Sofia ref. 115842
BIOPROTECTION SYSTEMS CORPORATION
participó en un
H2020:
H2020-JTI-IMI2-2014-02-single-stage
The proposal, VSV-EBOVAC, directly addresses the topic 1 of the IMI2 call on Ebola by supporting the clinical development of a highly promis...
2015-03-19 - 2019-02-28 | financed
2015-03-19 - 2019-02-28 | financed
* No data from the current company are not available.